Every weekend, I dig into our filings tracker looking for the biggest conviction buys — and this week, we saw a mix of heavyweight investors, executives, and even policymakers stepping in.
Let’s take a look:
International Tower Hill Mines $THM led the week with a $12.5M purchase from Paulson & Co.
When a big name like that is putting fresh capital to work, it’s worth paying attention. I guess Wall Street hasn’t lost interest in the precious metals trade just yet.
Home BancShares $HOMB saw a ~$2.7M purchase from its Chairman & CEO.
This is exactly the type of insider activity we focus on — when top leadership is buying their own stock, it reflects confidence in the company’s future.
Over in health care, Sutro Biopharma $STRO saw Perceptive Advisors file an original 13G, reporting a 5.40% stake.
They’re a well-known biotech fund, and when they initiate a position like this, it signals high-conviction.
Goldman Sachs $GS also made the list, with a purchase from Representative
Maria Elvira Salazar.
Congressional buying doesn’t always get the same attention, but it’s still meaningful insider activity — and this one stands out due to the deregulation taking place in the banking industry.
Finally, Rezolve AI $RZLV saw a $3.25M buy from its CEO.
When the person running the company steps in with size, it signals conviction that the stock price is headed higher. This one is particularly interesting as it is a short squeeze candidate as well.
